The research, which is set to end in March 2022, will enroll 150 volunteers and look at how a combination of the two vaccines triggers an immune response. The study will be conducted in five medical facilities in Moscow and St. Petersburg.
The developers of Sputnik V proposed combining the shots to AstraZeneca in November, suggesting it could increase the effectiveness of the British vaccine. AstraZeneca also announced a study to test the combination in December.
Both vaccines use similar technology, employing a harmless virus to deliver genetic material from the spike protein of COVID-19 into the body, which then prompts an immune response.
Read the original story here.
Sign in or become a tippinsights member to join the conversation.
Just enter your email below to get a log in link.